Search Results

Displaying Results 2576-2600 of 26632 "'D'"

Aug 18, 2026, 08:40 ET Bartell Machinery Announces Major Facility Expansion

innovation and production.While construction is still in its early stages, a 3D rendering provides a look at how Bartell Machinery's facility expansion will progress from initial construction through completion. View the 3D video rendering to see the expansion take shape from start to finish.About

More news about: Bartell Machinery


Aug 18, 2026, 08:37 ET Industrial Manufacturers Are Paying a Hidden "Silo Tax" on Every Capital Project-- ACS' Ntandem™ Model Helps Control Delivery Costs

designed and engineered to work together. ACS combines knowledge of building design and construction with expertise and understanding of equipment, R&D and production test, process systems, automation, data acquisition, and controls for industry leaders who require high-performance systems. ACS is

More news about: ACS


Aug 18, 2026, 08:36 ET Mindstream Energy Expands Al-Risha AI Infrastructure Ecosystem with Park Place Technologies and Orange Jordan

JordanHOUSTON and AMMAN, Jordan, Aug. 18, 2026 /PRNewswire/ -- Mindstream, LLC d/b/a Mindstream Energy ("Mindstream") today announced the continued expansion of the technology and infrastructure ecosystem supporting its Al-Risha Sovereign

More news about: Mindstream Energy


Aug 18, 2026, 08:30 ET FibroBiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair in Preclinical Study of Degenerative Joints

business; (b) expectations regarding the initiation, progress and expected results of FibroBiologics' R&D efforts and preclinical studies; and (c) the unpredictable relationship between R&D and preclinical results and clinical study results. Forward-looking statements speak only as of the date

More news about: FibroBiologics, Inc.


Aug 18, 2026, 08:10 ET Consano Bio Receives FDA Fast Track Designation for C-1101 in Chronic, Painful Lumbosacral Radiculopathy (LSR) or Chronic Sciatica

doi:10.1001/jama.2018.0152Dieleman JL, et al. JAMA. 2020;323(9):863-884. doi:10.1001/jama.2020.07343Deyo RA, Von Korff M, Duhrkoop D. Opioids for low back pain. BMJ. 2015;350:g6380. doi:10.1136/bmj.g6380

More news about: Consano Bio


Aug 18, 2026, 08:08 ET Rocket One Launches Swarm Stage AI Drone-Swarm Threat Emulation Platform for U.S. Military Counter-UAS

synchronized aircraft.AI Threat Builder — Designed to translate defined threat scenarios into coordinated multi-drone behaviors.3D Mission Preview — Enables swarm scenarios to be visualized and reviewed before flight.Custom Threat Scenarios — Enables new swarm

More news about: Rocket One Inc.


Aug 18, 2026, 08:07 ET Nine Ocean Tomo Experts Named to the 2026 IAM Strategy 300 - The World's Leading Intellectual Property Strategists

any other public accounting services. J.S. Held is not a law firm and does not provide legal advice.  Securities offered through PM Securities, LLC, d/b/a Phoenix IB or Ocean Tomo Investments, a part of J.S. Held, member FINRA/SIPC.  All rights reserved.Contact:Kristi L. Stathis

More news about: J.S. Held


Aug 18, 2026, 08:04 ET Evogene Reports Second Quarter and First Half 2026 Financial Results

is mainly attributable to lower R&D expenses in Casterra and AgPlenus, which were partially shifted to Evogene as the Company redirected its R&D efforts toward activities that are core to, and support the execution of, its new strategy.  The decrease in R&D expenses was partially offset by

More news about: Evogene


Aug 18, 2026, 08:04 ET Enlil Unveils Governed AI Foundation to Ready Medical Device Makers for AI-Assisted Regulatory Review

device and life sciences organizations. Designed to support regulatory readiness across the product lifecycle, Enlil connects quality, regulatory, R&D, manufacturing, and operations teams around a unified system of record. By structuring product data for traceability, auditability, and real-time visibility,

More news about: Enlil, Inc.


Aug 18, 2026, 08:00 ET KLA Legal Opens Doors After 90+ Depart Cipriani & Werner

professionals in cybersecurity and privacy and offers unique expertise in life sciences, technology E&O, media, digital health and healthcare, D&O and complex litigation. KLA Legal's offices are fully virtual and will feature professionals in Pennsylvania, New Jersey, New York, Delaware

More news about: KLA Legal


Aug 18, 2026, 08:00 ET AbbVie Announces 2026 AbbVie Immunology Scholarship Recipients, Celebrating 10 Years of Support

https://files.eric.ed.gov/fulltext/EJ1483220.pdf.    3 Lemly, D. et al. (2014) "College Health Service Capacity to Support Youth with Chronic Medical Conditions." Pediatrics. 2014 Nov;134(5):885–891. doi: 

More news about: AbbVie


Aug 18, 2026, 07:55 ET NovoEd Honored with 14 Brandon Hall Group™ 2026 HCM Excellence Awards® Alongside Client Partners 3M, Abbott, Kohler, and The HOW Institute for Society

developing innovative leadership development programs and supporting corporate culture and company strategy, the AI-powered NovoEd Platform enables L&D teams to deliver a workforce prepared to serve the current and future needs of their businesses. "It is a distinct honor for the NovoEd team

More news about: NovoEd


Aug 18, 2026, 07:36 ET Cove Capital Investments Adds Another Asset to Its Growing Portfolio of Debt-Free Delaware Statutory Trust Offerings After Acquiring 29,000-Square-Foot Retail Property to Form Its Shreveport Opportunity 120 DST

successfully completed the acquisition of a 29,000-square-foot retail asset located in Shreveport, Louisiana. The latest offering is structured under Regulation D, Rule 506(c) that seeks to raise $7,068,288 in equity from accredited investors.

More news about: Cove Capital Investments


Aug 18, 2026, 07:30 ET Eltek Ltd. Reports Second-Quarter 2026 Results

defense, aerospace and medical industries in Israel, the United States, Europe and Asia.Eltek was founded in 1970. The Company's headquarters, R&D, production and marketing center are located in Israel. Eltek also operates through its subsidiary in North America and by agents and distributors

More news about: Eltek Ltd.


Aug 18, 2026, 07:05 ET ADAMA Reports Second Quarter & First Half 2026 Results

by 13% in Q2 2026 and by 8% in H1 20264 Reported operating expenses include Sales and Marketing, General and Administration and R&D and include credit and other asset impairments (not inventory), other operating income and expenses as well as income from disposal of assets.5 For

More news about: ADAMA Ltd.


Aug 18, 2026, 07:00 ET Genprex Selects Leading Clinical and Commercial Contract Development and Manufacturing Organization for Manufacturing Scale Up of Diabetes Gene Therapy

patients to optimize treatment.Genprex's diabetes gene therapy product candidate is under development as a potential treatment for both T1D and T2D. In T1D, the drug candidate is designed to work by transforming alpha cells in the pancreas into functional beta-like cells, which can produce insulin

More news about: Genprex, Inc.


Aug 18, 2026, 07:00 ET Cypherpunk Technologies Launches World's Largest Zcash Mining Fleet

significant changes to the Company's financial statements, such as reduced revenue, reduced gross margins, and reduced net income or increased net loss; (d) the risk that the price of the Company's common stock may be highly correlated to the price of ZEC; (e) the risk that the Company will fail to realize

More news about: Cypherpunk Technologies Inc.


Aug 18, 2026, 07:00 ET Cypherpunk Technologies Launches World's Largest Zcash Mining Fleet

significant changes to the Company's financial statements, such as reduced revenue, reduced gross margins, and reduced net income or increased net loss; (d) the risk that the price of the Company's common stock may be highly correlated to the price of ZEC; (e) the risk that the Company will fail to realize

More news about: Cypherpunk Technologies Inc.


Aug 18, 2026, 06:46 ET Tradr Debuts First-to-Market ETFs on Meta, AXT, Coherent & Lightwave Logic

leverage; (b) understand the consequences of seeking inverse and leveraged investment results; (c) for short ETFs, understand the risk of shorting; (d) intend to actively monitor and manage their investment. Fund performance will likely be significantly different than the benchmark over periods longer

More news about: Tradr ETFs


Aug 18, 2026, 06:24 ET 매버릭스, 쿼크스 뉴욕에서 AI 시대의 신뢰할 수 있는 인간 데이터의 중요성 강조

multimedia:https://www.prnewswire.com/kr/news-releases/uB9E4uBC84uB9ADuC2A4u002Cu002DuCFFCuD06CuC2A4u002DuB274uC695uC5D0uC11Cu002Du0061u0069u002DuC2DCuB300uC758u002DuC2E0uB8B0uD560u002DuC218u002D-302853978.htmlSOURCE

More news about: Mavrix


Aug 18, 2026, 06:00 ET Smoothie King Introduces the First-Ever Delicious and Nutritious GLP-1 Support Pumpkin Smoothie

to meet an emerging need when we first introduced the first GLP-1 Support Menu in QSR in 2024," said Lori Primavera, Vice President of R&D and Product Marketing at Smoothie King. "Now with the Slim-N-Trim GLP-1 Pumpkin Smoothie, we're continuing to lead the category by proving

More news about: Smoothie King


Aug 18, 2026, 06:00 ET Brighter rooms. Bigger screens. Smarter choices: Panasonic TV Expands Its 2026 U.S. Lineup with OLED, Mini-LED and QLED Models

[3] Dolby, Dolby Vision, Dolby Atmos, Dolby Audio and the double-D symbol are trademarks or registered trademarks of Dolby Laboratories Licensing Corporation in the United States and/or other countries. Other trademarks

More news about: SKYWORTH USA


Aug 18, 2026, 05:18 ET Fractal Wins US$17M+ Multi-Year AI Deal with a Fortune 500® U.S. Healthcare Organization

by embedding AI into critical decisions across business functions and industry verticals.Fractal invests more than 6% of its revenue in AI R&D, supporting foundational AI research, product development, and IP creation that address both immediate client needs and long-term technological advancement.

More news about: Fractal Analytics Limited


Aug 18, 2026, 05:02 ET Harbour BioMed Announces NMPA Approval of IND Application for HBM7004 for the Treatment of Advanced Solid Tumors

antibody therapeutics in immunology, oncology and other areas. The Company is building a robust portfolio and differentiated pipeline through internal R&D capability, strategic global collaborations in co-discovery and co-development, and selective acquisitions.Our proprietary antibody technology

More news about: Harbour BioMed


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.